Arcadia Biosciences, Inc.
General ticker "RKDA" information:
- Sector: Consumer Staples
- Industry: Food Products
- Capitalization: $5.7M (TTM average)
Arcadia Biosciences, Inc. follows the US Stock Market performance with the rate: 5.9%.
Estimated limits based on current volatility of 2.3%: low 3.56$, high 3.73$
Factors to consider:
- Total employees count: 48 as of 2015
- US accounted for 94.4% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.03$, 9.08$]
- 2025-12-31 to 2026-12-31 estimated range: [1.67$, 5.20$]
Financial Metrics affecting the RKDA estimates:
- Negative: with PPE of -1.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -115.70 <= 0.33
- Positive: Return on assets ratio (scaled to [-100,100]) of 24.21 > 6.04
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of -2.08 <= -0.15
- Positive: Inventory ratio change, % of -15.34 <= -0.75
- Positive: 41.86 < Shareholder equity ratio, % of 46.04 <= 63.39
- Positive: -8.75 < Industry operating profit margin (median), % of 0.28
Short-term RKDA quotes
Long-term RKDA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $7.42MM | $4.45MM | $5.04MM |
| Operating Expenses | $21.43MM | $10.56MM | $8.69MM |
| Operating Income | $-14.01MM | $-6.10MM | $-3.65MM |
| Non-Operating Income | $3.19MM | $0.78MM | $-0.66MM |
| R&D Expense | $1.51MM | $0.06MM | $0.05MM |
| Income(Loss) | $-10.81MM | $-5.32MM | $-4.31MM |
| Taxes | $0.01MM | $0.01MM | $-0.01MM |
| Profit(Loss)* | $-15.61MM | $-13.98MM | $-7.04MM |
| Stockholders Equity | $21.03MM | $12.84MM | $6.22MM |
| Inventory | $2.32MM | $1.96MM | $0.90MM |
| Assets | $28.92MM | $19.70MM | $13.52MM |
| Operating Cash Flow | $-13.98MM | $-15.29MM | $-9.63MM |
| Capital expenditure | $0.07MM | $0.01MM | $0.02MM |
| Investing Cash Flow | $1.42MM | $-4.34MM | $7.34MM |
| Financing Cash Flow | $4.52MM | $5.51MM | $0.01MM |
| Earnings Per Share** | $-26.05 | $-11.30 | $-5.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.